ClassID:

21521

A61K51/025 - CPC Classification

Classification description:

Preparations containing radioactive substances for use in therapy or testing characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus inorganic Tc complexes or compounds

Recent Application in this class:
#1
20260132215
2026-05-14

COMPOSITIONS AND METHODS RELATED TO TUMOR ACTIVATED ANTIBODIES TARGETING PSMA AND EFFECTOR CELL ANTIGENS

#2
20260102523
2026-04-16

PHARMACEUTICAL COMPOSITION COMPRISING TETROFOSMIN AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF

#3
20250367333
2025-12-04

LIPID NANOPARTICLE FOR RADIATION THERAPY, MANUFACTURING METHOD, COMBINATION COMPOSITION, AND KIT

#4
20250228982
2025-07-17

OXIDATIVE NANOPARTICLES FOR USE IN THE TREATMENT OF DISEASES AND MEDICAL CONDITIONS

#5
20250205513
2025-06-26

Manganese Oxide radiotherapy source

#6
20250108135
2025-04-03

TERAGNOSTIC METHOD FOR CANCER PATIENTS

#7
20250049409
2025-02-13

METHODS OF QUANTIFYING SKELETAL MUSCLE PERFUSION USING PET IMAGING

#8
20240366817
2024-11-07

Alpha-emitter sources

#9
20240285816
2024-08-29

FORMULATIONS FOR RADIOTHERAPY AND DIAGNOSTIC IMAGING

#10
20240050602
2024-02-15

PARTICLES FUNCTIONALIZED WITH THERAPEUTIC RADIOISOTOPES AND METHODS OF MAKING AND USE THEREOF

#11
20240050598
2024-02-15

PHARMACEUTICAL COMPOSITION COMPRISING TETROFOSMIN AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF

#12
20230277697
2023-09-07

THERAGNOSTIC METHOD FOR CANCER PATIENTS

#13
20230263914
2023-08-24

Benzene ring-containing glucose derivative and use thereof

#14
20230110178
2023-04-13

Macrocyclic Chelators and Methods of Use Thereof

#15
20230107978
2023-04-06

High Specific Activity Preparation of F-18 Tetrafluoroborate

#16
20220212033
2022-07-07

Strontium sealed source

#17
20220168452
2022-06-02

TISSUE SPACERS

#18
20220081317
2022-03-17

METAL-MOLYBDATE AND METHOD FOR MAKING THE SAME

#19
20220017382
2022-01-20

METAL-MOLYBDATE AND METHOD FOR MAKING THE SAME

#20
20210402014
2021-12-30

COMPLEX POLYSACCHARIDE-BOUND RADIOISOTOPE CHELATES AND METHODS OF TREATING MALIGNANCIES THEREWITH

#21
20210402013
2021-12-30

FORMULATIONS FOR RADIOTHERAPY AND DIAGNOSTIC IMAGING

#22
20210361785
2021-11-25

Pharmaceutical compositions of sulfur colloid and processes thereof

#23
20210283280
2021-09-16

COMPLEX POLYSACCHARIDE-BOUND RADIOISOTOPE CHELATES AND METHODS OF TREATING MALIGNANCIES THEREWITH

#24
20210225547
2021-07-22

High specific activity preparation of F-18 tetrafluoroborate

#25
20210190759
2021-06-24

Composition for detecting hydrogen sulfide or measuring hydrogen sulfide concentration and composition comprising same as effective ingredient for diagnosing or imaging in vivo inflammation, tissues having hypoxic damage, or cancer

#26
20210187129
2021-06-24

Diagnostic usages of short-lived radiopharmaceuticals

#27
20210177821
2021-06-17

Androgen Receptor Modulator And Uses Thereof

#28
20210145987
2021-05-20

Pharmaceutical composition comprising tetrofosmin and pharmaceutically acceptable salts thereof

#29
20210128945
2021-05-06

Wet preparation of radiotherapy sources

#30
20210047199
2021-02-18

TITANIUM-MOLYBDATE AND METHOD FOR MAKING THE SAME

#31
20200353105
2020-11-12

Macrocyclic chelators and methods of use thereof

#32
20200276230
2020-09-03

PARTICLES FOR THE TREATMENT OF CANCER IN COMBINATION WITH RADIOTHERAPY

#33
20200234837
2020-07-23

Method of producing TC-99M by using nuclear resonance fluorescence

#34
20200085977
2020-03-19

Diagnostic usages of short-lived radiopharmaceuticals

#35
20200078476
2020-03-12

Aryl ethene derivative and pharmaceutical composition containing same as active ingredient

#36
20200046860
2020-02-13

Systems and Methods for the Detection of Hydroxychloroquine-Mediated Cardiotoxicity

#37
20200023085
2020-01-23

Method for labeling radioisotope radiolabeling compound and kit comprising the same for labeling radioisotope

#38
20190388570
2019-12-26

Imaging agents and uses thereof

#39
20190368046
2019-12-05

BODY COMPRISING AN OXIDE OF LANTHANIDE SUPPORTED ON A SULPHUR CONTAINING CARBON BASED PARTICLE AND A METHOD OF PREPARATION THEREOF

#40
20190336791
2019-11-07

Strontium sealed source

#41
20190311819
2019-10-10

Method of producing radionuclides and apparatus therefore

#42
20190290232
2019-09-26

Systems and methods for enhanced diagnosis of transthyretin cardiac amyloidosis

#43
20190282715
2019-09-19

FORMULATIONS FOR RADIOTHERAPY AND DIAGNOSTIC IMAGING

#44
20190262482
2019-08-29

Pharmaceutical composition comprising fluorine-18 labelled gases

#45
20190216956
2019-07-18

COMPOSITIONS FOR RADIOTHERAPY AND USES THEREOF

#46
20190167820
2019-06-06

NOVEL ARYL ETHENE DERIVATIVE AND PHARMACEUTICAL COMPOSITION CONTAINING SAME AS ACTIVE INGREDIENT

#47
20190062396
2019-02-28

Composition comprising recombinant human thyroid stimulating hormone and method for producing recombinant human thyroid stimulating hormone

#48
20190021608
2019-01-24

CD206+ Macrophage-Specific Molecular Imaging Probe Compositions and Methods and the Noninvasive Quantification of Arterial Wall Macrophage Infiltration in Humans

#49
20180339047
2018-11-29

Copper-cysteamine and methods of use

#50
20180244536
2018-08-30

Metal-molybdate and method for making the same

#51
20180244535
2018-08-30

TITANIUM-MOLYBDATE AND METHOD FOR MAKING THE SAME

#52
20180103620
2018-04-19

METHODS AND MATERIALS FOR USING TRANSGENIC NON-HUMAN ANIMALS EXPRESSING SODIUM IODIDE SYMPORTER POLYPEPTIDES TO MONITOR PATHOLOGICAL PROCESSES, DISEASE PROGRESSION, OR THERAPEUTIC RESPONSES OVER TIME

#53
20180036439
2018-02-08

COUPLED IDENTIFICATION AND TREATMENT OF CANCER

#54
20180015188
2018-01-18

Methods of performing brachytherapy

#55
20170371042
2017-12-28

CONTRAST AGENT FOR OPTICAL IMAGING, USE THEREOF AND APPARATUS USING THE SAME

#56
20170323696
2017-11-09

RADIOPHARMACEUTICAL PRODUCTION SYSTEM, RADIOPHARMACEUTICAL PRODUCTION DEVICE, AND PRODUCTION METHOD FOR RADIOPHARMACEUTICALS

#57
20170266328
2017-09-21

Metal(loid) chalcogen nanoparticles as universal binders for medical isotopes

#58
20170182166
2017-06-29

Copper-cysteamine and methods of use

#59
20170095218
2017-04-06

Single Photon Emission Computed Tomography Imaging Method

#60
20170000911
2017-01-05

Radiotherapeutic particles and suspensions

#61
20160296468
2016-10-13

Cervicouterine device that increases protection against the risk of contracting cervicouterine cancer

#62
20160144061
2016-05-26

Compositions and Imaging Methods Comprising Detectably Labeled Phosphatidylethanolamine-Binding Peptides

#63
20150367003
2015-12-24

Low-density magnesia-alumina-silica (MAS) microparticles for radiotherapy and/or radioimaging

#64
20150320895
2015-11-12

Radioactive nanoparticles and methods of making and using the same

#65
20150273089
2015-10-01

METHOD OF TREATING CANCER

#66
20150202336
2015-07-23

Loading Technique for Preparing Radionuclide Containing Nanoparticles

#67
20150157743
2015-06-11

Dose synthesis card for use with automated biomarker production system

#68
20150064107
2015-03-05

IMAGING AGENT

#69
20140356282
2014-12-04

Mo compounds as accelerator targets for production of Tc

#70
20140335017
2014-11-13

Strontium phosphate microparticle for radiological imaging and therapy

#71
20140271456
2014-09-18

RADIOTRACER IMAGING USING SODIUM IODIDE SYMPORTER POLYPEPTIDES

#72
20140199236
2014-07-17

Androgen receptor modulator and uses thereof

#73
20140134104
2014-05-15

Cancer therapy

#74
20140093451
2014-04-03

Coupled identification and treatment of cancer

#75
20140065068
2014-03-06

Vitamin-targeted imaging agents

#76
20130343988
2013-12-26

Pyrido [2, 3-D] pyrimidin-7-one compounds as inhibitors of P13K-Alpha for the treament of cancer

#77
20130237687
2013-09-12

Vitamin-targeted imaging agents

#78
20130230458
2013-09-05

Cell Permeable Inhibitors of Anaphase Promoting Complex

#79
20120314828
2012-12-13

Method and device for producing Tc

#80
20120276002
2012-11-01

CONTRAST AGENT FOR OPTICAL IMAGING, USE THEREOF AND APPARATUS USING THE SAME

#81
20120213698
2012-08-23

Loading technique for preparing radionuclide containing nanoparticles

#82
20120164071
2012-06-28

Compositions and methods comprising phosphatidylethanolamine-binding peptide derivatives

#83
20120070371
2012-03-22

Low-density magnesium-aluminum-silicate (MAS) microparticles for radiotherapy and/or radioimaging

#84
20110318265
2011-12-29

Coupled identification and treatment of cancer

#85
20110250107
2011-10-13

Column geometry to maximize elution efficiencies for molybdenum-99

#86
20110087003
2011-04-14

GLYCOPEPTIDE COMPOSITIONS

#87
20110038796
2011-02-17

Method of nuclear medical photography using dual-isotopes

#88
20100236958
2010-09-23

Radiopharmaceutical composition

#89
20100209340
2010-08-19

PYRIDO [2, 3-D] PYRIMIDIN-7-ONE COMPOUNDS AS INHIBITORS OF P13K-ALPHA FOR THE TREATMENT OF CANCER

#90
20090324499
2009-12-31

Vitamin-targeted imaging agents

#91
20090155167
2009-06-18

AUTOMATED METHOD

#92
20070218009
2007-09-20

Lanthanide rich nanoparticles, and their investigative uses in MRI and related technologies

#93
20070031334
2007-02-08

Vitamin-targeted imaging agents

#94
20070009437
2007-01-11

Intracellular trapping of radionuclides by enzyme-mediated reduction

#95
20060198786
2006-09-07

Glycopeptide compositions

#96
20060165594
2006-07-27

Preparation of m(co)3-complexes by solid phase techniques via metal assisted cleavage from the solid support

#97
20050186134
2005-08-25

Method for preparing technetium-labeled antimony sulfide nanocolloid